Cardio Diagnostics Total Risk Alpha
| CDIO Stock | | | USD 2.29 -0.17 -6.91% |
Technical inputs supporting the Total Risk Alpha indicator for Cardio Diagnostics Holdings are shown here. Coverage differences may occur across instruments and market segments. Cardio Diagnostics has a market cap of 6.78 M, operating margin of -411.6%, ROE of -78.62%.
Trending Equities can help frame allocation decisions. This reflects a position in Cardio Diagnostics Holdings. The allocation framework shapes how individual positions are weighted. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in gross domestic product.
Cardio Diagnostics Holdings has current Total Risk Alpha of 2.54. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 2.54 | |
| ER[a] | = | Expected return on investing in Cardio Diagnostics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Cardio Diagnostics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Cardio Diagnostics Holdings lands at
#2 in total risk alpha compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors producing
46.21 in Maximum Drawdown for each unit of Total Risk Alpha. The spread between Maximum Drawdown and Total Risk Alpha for Cardio Diagnostics Holdings sits at
46.21 The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Cardio Diagnostics to Peers
Other Technical Indicators